Hypertension research - key publications using PLN antibodies
Please rate these pages to support our infographic project:
Get free premium widgets for your blog and website.
References
- Angelone, T. et al. 2008. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology. 149(10), pp.4780-4793.
- Boknik, P. et al. 2001. Enhanced protein phosphorylation in hypertensive hypertrophy. Cardiovascular Research. 51(4), pp.717-728.
- MacDonnell, S.M. et al. 2007. Calcineurin inhibition normalizes beta-adrenergic responsiveness in the spontaneously hypertensive rat. American Journal of Physiology-Heart and Circulatory Physiology. 293(5), pp.H3122-H3129.
Back to main infographic.
About us
Badrilla is a manufacturer of outstanding antibodies against cardiac proteins and phospho-proteins, and the manufacturer of leading kits for the study of protein S-palmitoylation.
Follow us on social
Contact us
We look forward to providing your favourite antibodies and kits
